Pamuk Bilsel
Chief Scientific Officer, FluGen, Inc,
USA
Biography
Pamuk Bilsel, Ph.D. is Chief Scientific Officer at FluGen, Inc. Prior to joining FluGen in 2008, she was at Pharmexa-Epimmune where she developed DNA vaccines against influenza and malaria. At Pentamer Pharmaceuticals, a San Diego start-up, she worked on subunit vaccines using virus-like particle technology. Preceding that Dr. Bilsel was at Aviron generating live attenuated influenza vaccine strains in addition to studies with the cold-adapted influenza vaccine which was eventually launched as MedImmune’s FluMist®. Dr Bilsel received her Ph.D. from the University of Nevada, Reno and did her post-doctoral training at St. Jude Children’s Research Hospital with Dr. Yoshihiro Kawaoka.
Abstract
Speaker Presentations
Speaker PDFs